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EFFECT OF VARIOUS CONCENTRATIONS SUPPLEMENTED MG2+ 
ON THE OSTEOGENIC BEHAVIOR OF NORMAL HUMAN OSTEOBLASTS 
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Biomaterials 
ABSTRACT 
Background: In applications on dental/orthopedic implants and bone 
regeneration, biomaterials contained magnesium have been widely used. 
However, the mechanism underlying the biologic effects is still largely unknown. 
In addition, previous reports of osteogenic effect of magnesium mainly relied on 
studies using ATCC osteosarcoma cell lines but not normal human osteoblasts. 
Objective: This study was designed to test the effect of magnesium on 
osteogenic phenotypic behaviors of normal human osteoblasts.  
Methods: Normal human osteoblasts derived from human alveolar bone were 
cultured in triplicate in growth media with varies concentrations of supplemental 
magnesium: 0.5mM, 1mM, 2mM, 4mM, 8mM and 16mM as the study groups and 
0mM as a control group for the time intervals of 7 days, 10 days, 14 days and 21 
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days. Cell proliferation was measured by crystal violet dye staining. Expression of 
osteocalcin was measured by Quantikine Elisa and mineralization of cultures was 
measured by Alizarin Red staining. The data were normalized per cell basis. 
Statistical analysis was done using ANOVA and Student’s t test.  
Results: Osteocalcin expression was upregulated in groups with supplemented 
magnesium at 0.5mM (1.16folds, p<0.01 ), 1.0mM (1.22folds, p<0.01 ), 2.0mM 
(1.37folds, p<0.01 ) at day 21 compared to control, while at 4mM ( p<0.01 ) and 
above showed down-regulation. Alizarin Red stained cultures showed higher 
degree of mineralization at 1mM ( p=0.0228 ) and 2mM ( p=0.0142) compared to 
control. Groups with 4mM and above showed less calcium deposition. Similar 
results have been gained also on day 10 and day 14 for both assays.  
Conclusion: Osteogenesis of normal human osteoblasts could be significantly 
upregulated by 2mM supplemental magnesium. These data are important for 
manufacturing magnesium-containing biomaterials for bone tissue regeneration 
and implants. 
 
 
 vii 
Table of Contents 
Reader’s approval………………………………………………ii 
Acknowledgement.................................................................iii 
Abstract.................................................................................v 
Table of contents...................................................................vii 
List of tables..........................................................................xi 
List of figures.........................................................................xii 
List of abbreviations and Chemical Formulas.......................xvii 
1. Introduction...................................................................................1 
1.1. Significance of bone to dental implant application.................2 
1.2. Differentiation of osteoblast cells……………………...............6 
1.3. Importance of normal human osteoblast cells…….................10 
 viii 
1.4. Osteogenesis by different materials…………………...............12 
1.5. Magnesium capacities in the human cell…………...................17 
1.6. Regulation of Magnesium concentration in human body.........19 
1.7. Clinical applications of magnesium as stent………..................20 
1.8. Biocorrosion of magnesium…………………………..................22 
1.9. Metallic biomaterials clinical application on hard tissue…........24 
1.10. Rationale and clinical significance for this research...............26 
2. Hypothesis.......................................................................................28 
3. Objective of the study......................................................................30 
4. Material and methods......................................................................33 
  List of materials................................................................................34 
  List of chemicals, enzymes, growth media and kits.........................39 
 ix 
  List of equipment used....................................................................44 
4.1. Approvals and training.............................................................48 
4.2. Materials..................................................................................49 
4.2.1. Agents and cells...........................................................49 
4.2.2. Tissue culture maintenance and expansion.................52 
4.2.3. Determination of the optimal seeding concentration....53 
4.2.4. Attachment efficiency assay.........................................54 
4.2.5 Proliferation rates by Crystal Violet stain……................55 
4.2.6. Alkaline phosphatase assay kit.....................................57 
4.2.7. Osteocalcin ELISA assay..............................................61 
4.2.8. Mineralization assay by Alizarin Red S Staining………66 
5. Statistical analysis...........................................................................68 
 x 
6. Results........................................................................................................70 
6.1 Attachment efficiency...........................................................................71 
6.2. Proliferation rate affected by Mg2+ at various concentrations..............75 
6.3. ALP activity affected by Mg2+ at various concentrations .....................82 
6.4. Osteocalcin expression affected by Mg2+ at various concentrations…89 
6.5. Mineralization affected by Mg2+ at various concentrations...................96 
7. Discussion.................................................................................................102 
8. Conclusion.................................................................................................115 
9. Future studies............................................................................................117 
10. References..............................................................................................119 
11. Vita..........................................................................................................144 
 
 xi 
 List of Tables 
Table 1: List of materials..............................................................................34 
Table 2: List of chemicals, enzymes, growth media and kits.......................39 
Table 3: List of equipment used...................................................................44 
Table 4: Preparation volumes of standard curve dilutions for ALP assay....59 
Table 5: Preparation volumes of standard curve dilutions for osteocalcin 
ELISA assay..................................................................................63 
Table 6: Osteoblast cells attachment efficiency...........................................72 
 
 
 
 
 xii 
List of Figures 
Figure 1: Normal human osteoblasts were cultured for 16 hours with media 
containing supplemental Mg2+ ranging from 0.5 to 16mM............74 
Figure 2: Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time 
period of 7 days............................................................................77 
Figure 3: Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time 
period of 10 days..........................................................................78 
Figure 4: Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time 
period of 14 days..........................................................................79 
Figure 5: Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time 
period of 21 days..........................................................................80 
 xiii 
Figure 6: Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time 
period of 7, 10, 14 and 21 days. ................................................81 
Figure 7: Alkaline phosphatase activity of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7 days...............................................84 
Figure 8: Alkaline phosphatase activity of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 10 days...........................................85 
Figure 9: Alkaline phosphatase activity of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 14 days...........................................86 
Figure 10: Alkaline phosphatase activity of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 21 days...........................................87 
 xiv 
Figure 11: Alkaline phosphatase activity of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7, 10, 14 and 21 days...................88 
Figure 12: Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7 days...........................................91 
Figure 13: Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 10 days.........................................92 
Figure 14: Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 14 days.........................................93 
Figure 15: Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 21 days.........................................94 
 xv 
Figure 16: Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7, 10, 14 and 21 days.....................95 
Figure 17: Mineralization of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7 days................................................................97 
Figure 18: Mineralization of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 10 days..............................................................98 
Figure 19: Mineralization of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 14 days..............................................................99 
Figure 20: Mineralization of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 21 days.............................................................100 
 xvi 
Figure 21: Mineralization of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7, 10, 14 and 21 days......................................101 
 
 xvii 
List of Abbreviations and Chemical Formulas 
AGA: arginine-glycine-aspartic acid 
ALP: alkaline phosphatase 
ANOVA: analysis of variance 
ARS: Alizarin Red S 
ATCC: American Type Culture Collection 
BAFO: bone area fraction occupancy 
CaCl2: calcium chloride 
CITI: collaborative institutional training Initiative  
DMEM: Dulbecco's modified Eagle's Medium 
ECM: extracellular matrix 
EDTA: ethylenediaminetetraacetic acid 
 xviii 
FBS: fetal bovine serum 
FE-SEM: field emission scanning electron microscope  
HA: hydroxyapatite 
HR: hours 
IBC: institutional biosafety committee 
IRB: institutional review board 
KCl: potassium chloride 
NaCl: sodium chloride 
MgCl2: magnesium chloride 
MUP: 4-methylumbelliferyl phosphate disodium salt 
NaHCO3: sodium bicarbonate 
NaH2PO4: monosodium phosphate 
 xix 
NHOst: normal human osteoblast 
OCN: osteocalcin 
OI: osseointegration 
PBS: phosphate buffered saline solution 
pNPP: para nitrophenyl phosphate 
RE: rare earth 
RT: room temperature 
SF: silk fibroin 
SS: silk scaffolds 
 
 
 1 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 2 
1. INTRODUCTION 
1.1.  Significance of bone to dental implant application 
Humans are born with about 300 soft bones. During late childhood and 
adolescence those soft bones are slowly replaced by hard bones. Some of the 
bones even fuse together, reducing the bone number in the adult human body to 
only 206. Bone is often considered just a protective and supportive framework for 
the body. In reality, bones are living tissue that is in constant change. This change 
is essential in order to keep all bone functions intact. Initially, bones increase in 
size and shape, a process called modeling. In early adulthood, constant bone 
renewal takes place. This process is called remodeling. Modeling and remodeling 
must occur at the same time for effective bone formation. This requirement is 
called coupling. (Chiras, 2011) 
Bones have many functions. First of all, bone is a rigid structure that 
supports anchorage of muscles to enable movements in all vertebrates. It also 
acts as protective outer layer to shield vulnerable organs such as brain, spinal 
cord and internal organs from injuries (N. Rosenberg, Rosenberg, & Soudry, 
2012). It also is an important store of minerals for physiological homeostasis 
including both acid-base balance and calcium or phosphate maintenance. (Arnett, 
2007) Its solid characteristics are due to the calcified matrix which is composed of 
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inorganic components of calcium and phosphate, as hydroxyapatite, deposited on 
organic components, mainly collagen I, and 5% of non-collagenous proteins, such 
as osteopontin and osteocalcin (S. G. Kim, Lee, Lee, & Jang, 2014), etc. 
In general, bone consists of bone cells, an organic matrix, and inorganic 
minerals. Bone contains different bone cell types, each of them dedicated to 
distinct functions. For example, osteoblasts are the bone forming cells, regulating 
the mineralization of the extracellular collagen protein matrix in bone formation 
process. Osteoclasts on the other hand, remove the old bone matrix contributing 
in functions like maintenance and repair of bone. When osteoblasts are trapped in 
the matrix, they differentiate a different third type of cells, which is known as 
osteocytes. Osteocytes connect to each other via long channels called canaliculi. 
Through those interconnecting long channels, they can send messages and 
nutrients to each other even in long distances within the bone. Finally, 
undifferentiated mesenchymal cells, called also osteoprogenitor cells, give rise to 
many other cell types including osteoblasts, osteoclasts, fibroblasts, 
chondroblasts and bone marrow stromal cells depending of the nature of the 
stimulus and microenvironmental needs.  
Thus, bone cells regulate the formation and turnover or resorption of bone, 
which is a key step in regulating body calcium, magnesium, and phosphate levels. 
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This maintenance of inorganic ion levels, or homeostasis, is one of the major 
non-mechanical functions of bone. (Boskey, 2007)  
Rehabilitation with implant-supported prostheses is considered a feasible 
therapy for edentulous patients. Since the 1980s, when Dr. Branemark 
established the first intraosseous dental implantations to partial or full arch 
edentulous patients (Albrektsson, Brånemark, Hansson, & Lindström, 1981), the 
implant underlying bone quantity and quality became an important factor essential 
for the success of new dental implantations.  
Currently, more and more patients undergoing the dental implant surgery 
treatment. The insertion of four to six implants into the interforaminal area of the 
edentulous mandible provides great stability for implant-supported prostheses 
with a distal cantilever (Chao, Meijer, Van, & Versteegh, 1995; Chee & Jivraj, 
2006). However, factors such as oral hygiene, the inter-arch relationship, 
treatment cost, patient acceptance, and masticatory function may influence 
treatment options (Ekelund, Lindquist, Carlsson, & Jemt, 2003). 
In this sense, the bone availability and inter-arch space should be 
appropriate for the placement of implants in the mandibular anterior region (D 
Mericske-Stern, Taylor, & Belser, 2000). The volume and quality of the alveolar 
ridge influence the biomechanical and esthetic results, the stability of the implant- 
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supported prostheses, and the health of the surrounding tissues (de Almeida, 
Rocha, Assunção, Júnior, & Anchieta, 2010). After tooth loss, the structure of the 
mandibular bone undergoes a constant process of physiological resorption, which 
causes the decline of the alveolar perimeter and the expansion of the trabecular 
bone, decreasing the bone density. These factors may influence treatment with 
dental implants. The better the quality of the bone of the patient, the better the 
outcome for the implant treatments. (Faverani et al., 2014). Since then, many 
studies were conducted aiming to discover factors that would accelerate bone 
healing.  
Fast healing of bone, means not only higher implant success rate, but also 
shorter treatment process and minimal discomfort for patients that have 
undergone surgical procedures. 
To include all above described, to shorten the treatment process and 
minimalize the discomfort for patients after surgery or trauma is very essential to 
the clinicians, that makes to find out the factors to accelerate the healing.  
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1.2.  Differentiation of osteoblast cells 
Osteoblasts are specialized, terminally differentiated products of primitive 
mesenchymal stem cells with a single nucleus that synthesize the bone tissue. 
The differentiation process for mature osteoblasts is long. Initially they 
differentiate into osteoprogenitors, then pre-osteoblasts and finally into 
osteoblasts. (Pittenger et al., 1999) They are entrapped in matrix differentiate into 
osteocytes and compose 90–95% of the cells embedded in the mineralized matrix 
of bone. Mesenchymal progenitors appear as elongated fibroblasts within the 
outermost layers of the periosteum whereas mature osteoblasts are of cuboidal 
morphology and are in direct contact with the bone surface; preosteoblasts reside 
between the two populations. Preosteoblasts, but not mature osteoblasts, have 
been shown to actively divide in vivo. (Franz-Odendaal, Hall, & Witten, 2005).  
The main function of osteoblasts is to synthesize and secrete bone matrix, 
therefore they play a major role in bone tissue regeneration. Osteoblasts respond 
to mechanical stimuli to mediate changes in bone size and shape. However, 
individual osteoblast cells cannot make bone. Only organized in groups they are 
producing a calcium and phosphate-based mineral called hydroxyapatite, which 
would be deposited in a highly regulated order into the organic matrix and become 
a very rigid mineralized tissue (N. Rosenberg et al., 2012) called osteon. The 
osteon units account about 4~6% of cells of the bone tissue. (Capulli, Paone, & 
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Rucci, 2014) They synthesize very dense, crosslinked collagen, and several 
additional specialized proteins in much smaller quantities, including osteocalcin 
and osteopontin, which compose the organic matrix of bone.  
Low number of osteoblasts or limited osteoblast functions could also cause 
osteoporosis, a common skeletal disease in aged humans. 
Although the main function of osteoblasts is to synthesize the components 
of the bone matrix and control the resorption activity of osteoclasts, they are 
currently attributed with other functions as well related to the immune system, 
such as cytokine synthesis, stimulation and/or presentation of antigens to T 
lymphocytes and phagocytic capacity against different targets of different types 
and sizes. Besides synthesizing and secreting cytokines, osteoblasts are known 
to express receptors for different cytokines.  
Published research results indicate that osteoblasts play a key role in the 
initiation of T lymphocyte activation at bone infection sites, triggering the host 
immune response. For this reason, osteoblasts have been related to dendritic 
cells, with which they share antigenic expression and immune function. 
Osteoblasts can also modulate the percentage expression of antigens such as 
CD54, CD80, CD86, and HLA-DR and their phagocytic capacity, according to 
 8 
their degree of maturation and/or the presence of proinflammatory cytokines 
(Long, 2012). 
The differentiation development is induced by glycocorticoids, hormons, 
growth factors and cytokines among other mediators. Osteoblast development is 
characterized by three stages in vitro and in vivo: (1) cell proliferation, (2) matrix 
maturation, and (3) matrix mineralization. (Lian & Stein, 1995).  
Fully mature osteoblasts are responsible for synthesizing the mineralized 
matrix by controlling the deposit of mineral salts. They are also responsible for 
forming the organic component of the bone matrix, which is a synthesis of: type I 
collagen; osteonectin; osteopontin; osteocalcin; alkaline phosphatase; growth 
factors; receptor activator of nuclear factor kB ligand (RANKL), essential for 
osteoclast differentiation; and the parathyroid hormone receptor (Repercussions 
of NSAIDS drugs on bone tissue: The osteoblast).  
Under in vitro experiments, matrix maturation and mineralization studies 
are usually enhanced by growing the target cells to full confluence and by adding 
specific osteogenic factors. (Kasperk et al., 1995). Analysis of the above 
mentioned expression markers are used to determine the successful transition of 
osteoblasts from one stage to the next one.  
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(1) During proliferation, several extracellular matrix proteins (procollagen I, 
TGF-β, and fibronectin) can be detected.  
(2) The matrix maturation phase is characterized by maximal expression of 
alkaline phosphatase. 
(3) In the matrix mineralization stage, genes for proteins such as 
osteocalcin, bone sialoprotein, and osteopontin are expressed and 
once mineralization is completed, calcium deposition can be visualized 
using various methods. 
In our laboratory, functional analysis of following expression proteins, 
Alkaline Phosphatase and Osteocalcin as well as a detection of functional 
mineralization are utilized to characterize the different osteoblast stages in vitro 
(Chen, 2000; Elbadawi, 2016; Lyu, 1999). The mineralization process of 
osteoblasts in vitro has also been used as a model for testing the effects of drug 
treatments and on bone cell differentiation and bone formation. (Kostenuik, 
Halloran, Morey-Holton, & Bikle, 1997; Kostenuik et al., 1999) 
 10 
1.3.  Importance of normal human osteoblast cells 
Up to now, most in vitro studies about bone development utilized 
osteosarcoma cell lines or non-human osteoblast cell lines. The main reason is 
the easiness to obtain and maintain those cell lines. They are normally purchased 
from ATCC or other companies, or more conveniently, they are isolated from 
abundant animal bone. Although they are all called osteoblasts, their cellular 
properties or expression pattern is different from genuinely normal human 
osteoblast cells. Scientists from Dr.Chou’s lab (Thalanki, 2002) and others have 
detected differences in growth pattern, cell cycle regulation, cell differentiation, 
cell mineralization, and cell apoptosis behavior(Carinci, Palmieri, Pezzetti, 
Brunelli, & Ilaria, 2009; Pautke et al., 2004; Ruan & Grant, 2001) To pursue the 
optimal clinical application performance, scientists cannot rely on the data 
collected from studies that used osteosarcoma cell lines or animal osteoblast cell 
lines, because those cells don’t represent normal human osteoblast behavior. 
In addition it is known that other intrinsic body factors affect osteoblast 
behavior as well. Therefore for in vitro studies, the best choice is to utilize normal 
human osteoblast cells isolated from bone of healthy adults and utilize those as 
soon as critical cell numbers have been reached that allow experiments to be 
performed (earliest passage). The early passages of cells guarantee minimal 
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adaptation to new vitro conditions, which are very different from the vivo 
conditions in the human body.  
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1.4.  Osteogenesis by different materials 
Bone loss related to osteoporosis, trauma, cancer, and congenital 
abnormalities continues to be a serious fast-growing problem worldwide, and the 
annually associated orthopedic cost is tens of billions of dollars with a significant 
increase estimated for the coming decades. When bone loss is too severe to be 
regenerated by the routine mechanism of the human body, treatments with 
autologous grafts or artificial implants to enhance the process of osteogenesis are 
considered. 
Osteogenesis in bone remodeling is the process of laying down new bone 
material by cells called osteoblasts. It is synonymous with bone tissue formation. 
There are two processes resulting in the formation of normal, healthy bone 
tissue(Caetano-Lopes, Canhao, & Fonseca, 2007): Intramembranous ossification 
is the direct laying down of bone into the primitive connective tissue 
(mesenchyme), while endochondral ossification involves cartilage as a precursor. 
In fracture healing, endochondral osteogenesis is the most commonly occurring 
process, for example in fractures of long bones treated by plaster of Paris, 
whereas fractures treated by open reduction and internal fixation with metal plates, 
screws, pins, rods and nails may heal by intramembranous osteogenesis. 
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There are some studies showed the progress of osteogenesis could be 
up-regulated by different elements. In Ortiz et al. study, they added supplemented 
Ca ions in culture medium to observe the osteogenic effect on normal human 
osteoblast cells in vitro, which has a promising result revealed that the survivin 
expression could be significantly upregulated by calcium-enhanced normal 
human osteoblast cultures, which might correlate to subsequent upregulation of 
cell proliferation and differentiation(Ortiz & Chou, 2012).  
In Nacer et al. study, they tested the biocompatibility and osteogenesis of the 
castor bean polymer doped with silica (SiO2) or barium titanate (BaTiO3) 
nanoparticles in vivo on 12 rats through surgical procedure. The result showed 
BaTiO3 or SiO2 nanoparticles behaved like a biocompatible material, capable of 
allowing for progressive bone neoformation within its communicative porous 
structure, promoting induction and aggregation of bone cells over its surface and, 
subsequently, speed up the osteogenesis process(Nacer et al., 2015). 
Moreover, in Wei et al. study, they used the material carbon fiber-reinforced 
polyetheretherketone (CFRPEEK). It possesses an adjustable elastic modulus 
similar to cortical bone and that makes it a good potential material to replace 
surgical metallic implants. In their study, CFRPEEK–nanohydroxyapatite ternary 
composites (PEEK/n-HA/CF) with variable surface roughness have been 
successfully fabricated. The effect of surface roughness on their in vitro cellular 
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responses of osteoblast-like MG-63 cells (attachment, proliferation, apoptosis, 
and differentiation) and in vivo osseointegration is evaluated.  
The results show that the hydrophilicity and the amount of Ca ions on the 
surface are significantly improved as the surface roughness of composite 
increases. In cell culture tests, the composite with moderate surface roughness 
significantly increases cell attachment/proliferation and promotes the production 
of alkaline phosphatase (ALP) activity and calcium nodule formation when 
compared with the other groups.  
More importantly, the PEEK/n-HA/CF implant with appropriate surface 
roughness exhibits remarkably enhanced bioactivity and osseointegration in vivo 
in the animal experiment. These findings will provide critical guidance for the 
design of CFRPEEK-based implants with optimal roughness to regulate cellular 
behaviors, and to enhance biocompability and osseointegration.(Wei et al., 2015) 
Also, some studies showed interested on osteogenesis ability of silk fibroin 
(SF). It is a fibrous protein, which is produced mainly by silkworms and spiders. Its 
unique mechanical properties, tunable biodegradation rate and the ability to 
support the differentiation of mesenchymal stem cells along the osteogenic 
lineage, have made SF a favorable scaffold material for bone tissue engineering. 
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In Kim et al. study(K.-H. Kim et al., 2005); the bone regenerative efficacy of the 
membrane was evaluated in the calvarial defect of rabbits to examine the 
biocompatibility of the electrospun SF membrane, they investigated cell 
proliferation, morphology, and differentiation. The results showed that the cell 
numbers and osteocalcin expression were significantly increased in accordance 
with culture period. In in vivo test, a bony defect was applied with the material and 
observed after 8 weeks. At 12 weeks, the defect had completely healed with new 
bone. So the electrospun SF was shown to possess good biocompatibility and to 
enhance bone regeneration, and no evidence of any inflammatory reaction was 
confirmed in the in vivo study.  
In Meinel et al. study (Meinel et al., 2006) also focused on silk biomaterial, 
which were evaluated silk fibroin biomaterial scaffolds as osteopromotive matrices 
in critical sized mid-femoral segmental defects in nude rats. The experiment has 
been designed into four groups with different treatment and were assessed over 8 
weeks in vivo: silk scaffolds (SS) with human mesenchymal stem cells (hMSCs) 
that had previously been differentiated along an osteoblastic lineage in vitro 
(group I; pdHMSC/SS); SS with undifferentiated hMSCs (group II; udHMSC/SS); 
SS alone (group III; SS); and empty defects (group IV). 
The results showed that significantly greater bone volumes were observed 
with the pdHMSC/SS (group I) implants than with groups II, III or IV. These three 
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groups failed to induce substantial new bone formation and resulted in the 
ingrowth of cells with fibroblast-like morphology into the defect zone, which also 
demonstrated the pdHMSC/SS implants has the osteogenic ability and capacity to 
thrive towards the healing of critical size femoral segmental defects. 
In conclusion, numerous materials and elements have been studied the 
enhancement of osteogenesis process, but in this field magnesium still largely 
unknown, the importance of magnesium to human bone tissue will be described in 
the following chapters. 
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1.5.  Magnesium capacities in the human cell 
Magnesium is an important mineral that is needed to maintain normal 
physiological functions in human body. The human body contains around 25g 
magnesium. Most magnesium is bound and only less than 1% is free in blood 
serum. More than 60% of the bound magnesium in human body is found in bones 
and the rest in soft tissue.  
Within the human cell, magnesium (Mg2+) is the second most abundant 
cation. Determinations of total and free Mg2+ concentrations by electron probe 
X-rays microanalysis (EPXMA), 31P-NMR, selective Mg2+-electrode, 13C-NMR 
citrate/isocitrate ratio or fluorescent indicators consistently indicate total Mg2+ 
concentration ranging between 17 to 20mM in the majority of mammalian cell 
types examined (Romani & Scarpa, 1992; Wolf, Torsello, Fasanella, & Cittadini, 
2003). According to the distribution of binding sites within the cell the highest 
magnesium content is found in ribosomes and endoplasmic reticulum, followed by 
mitochondria and nuclei (Heaton, 1993). The concentration of the cytoplasmic 
Mg2+ pool is about 4-5 mM.  
Intracellular magnesium is mainly bound to nucleic acids, ATP, negatively 
charged phospholipids and proteins. Because of its abundance (5mM) and Mg2+ 
binding affinity, ATP constitutes the largest metabolic pool able to bind Mg2+ 
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within the cytoplasm. ATP known as the cellular energy source of the cells, has to 
be bound to magnesium ions in order to be active (Romani, 2011). Additionally 
around 300-600 enzymes need magnesium as cofactor to display their catalytic 
activity including the ones that are involved in synthesis of ATP, RNA and DNA.  
In spite of the importance of magnesium to various physiological and 
biochemical processes there is no indication that magnesium homeostasis is 
under specific tight hormonal control. This might be explained by an abundance of 
magnesium in the diet during evolution of man. Magnesium homeostasis in 
largely controlled by the kidney which secrets up to 120 mg surplus magnesium 
into the urine every day. Required magnesium is simply fulfilled by absorption 
from the gut, distribution of the needed amounts to the cells and kidney excretion 
(Vormann, 2003) 
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1.6.  Regulation of Magnesium concentration in human body 
Stored magnesium is mainly located in bone tissue, where it acts as a 
magnesium reservoir. Reduced concentrations of magnesium in blood plasma 
lead to rapid release of magnesium from bone. Conversely, increased 
concentrations of magnesium in plasma lead to magnesium storage in 
bones.Increase or decrease of extracellular magnesium concentration directly 
affects the process of mineralization and absorption of the bone tissue. (Kirkland, 
2013; Vormann, 2003; Witte, 2015; Wolf & Cittadini, 2003) Part of serum 
magnesium is adsorbed to the bone surface, which maintains the equilibrium with 
the extracellular magnesium. (Martini, 1999)  
Even though possible functions of magnesium in bone mineral were 
proposed, the biological functions of magnesium in bone metabolism have still not 
fully been investigated. (Kirkland, 2013; Staiger, Pietak, Huadmai, & Dias, 2006)  
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1.7.  Clinical applications of magnesium as stent 
Stents used as tubular implants for the mechanical support of stenotic 
arterial vessels were introduced in the 1990s. However, the initial concept of 
transluminal implantation of stainless steel coil springs was already described by 
Dotter in preclinical experiments in 1969 (Dotter, 1969).  
In recent years, metal or plastic stents have been implanted in the body 
permanently aiming to facilitate with problem areas. Stent endoprostheses are 
either self-expanding or balloon-expandable and are usually fabricated either as a 
wire mesh or a slotted tube. Polymer-based biodegradable stents developed so 
far still suffer from the major drawback of limited mechanical performance.  
Metallic materials on the other hand possess excellent mechanical 
properties and acceptable biocompatibities. Typical materials of permanent bare 
metal stents (BMS) are stainless steel and cobalt-chromium alloys for 
balloon-expandable stents, and nickel-titanium alloys for self-expanding 
stents(Hanawa, 2009). The vast majority of the stents used currently in clinics is 
made of stainless steels or cobalt–chromium alloys (Hanada, Matsuzaki, Huang, 
& Chino, 2013) It’s now widely acceptable that biodegradable metallic materials 
for stents may be more beneficial in the body than permanent metals because 
they help overcome a problem called late stent thrombosis.  
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Biodegradable Mg-based materials have the advantage to reduce or even 
eliminate this obstacle. Furthermore magnesium alloys have large strength/weight 
ratios, large fracture toughness, high tensile strength and are very light. In 
addition magnesium as an ion plays an important role in many biological functions 
(N. Zhao et al., 2014). For example, Mg is an essential element in the human 
body involved in the synthesis of proteins, activation of a variety of enzymes, 
regulation of the activities in the neuromuscular and central nervous system to 
ensure normal myocardial contraction and thermoregulation. In summary, Mg and 
Mg alloys provide the necessary mechanical support for tissue healing, cell 
growth and differentiation in the early stage, while natural degradation and 
reabsorption by surrounding tissues in the later stage make follow-up removal 
surgery unnecessarily(Sternberg et al., 2011). This complete degradation after 
tissue regeneration satisfies the increasing demand for better biomedical devices 
and functional tissue engineering biomaterials.  
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1.8.  Biocorrosion of magnesium 
As mentioned before, the biodegradable and biocompatible magnesium 
presents itself as a promising material. However, it is not the ideal material. The 
reason for that is the rapid degradation rate which takes place and which could 
lead to loss of mechanical integrity and release of high concentration of 
degradation products. Moreover, the corrosion of the magnesium alloy could has 
the risk of cytotoxicity (Fischer et al., 2010). 
To overcome this obstacle, the biocorrosion resistance of magnesium has 
to strengthen By adding appropriate elements to magnesium, magnesium alloy 
stents are expected to be able to perform better. The improved biomechanical 
functions would even support the arterial walls during the remodeling process 
over a period of 6–12 months and then magnesium alloys would progressively 
degrade.  
In the mean time, new RE elements are developed which are able to serve 
the purposes of alloying better than most of other bio-tolerable elements. The first 
biodegradable magnesium alloy stent was created by Biotronik, which was made 
from WE43. (Gong, Wang, Strich, & Zhou, 2015) The stent demonstrated good 
biocompatibility and clinical trial has shown very promising results. (Erbel et al., 
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2007) Also RE-containing magnesium alloys such as WE43 alloy and AE21 have 
therefore been subjected to extensive in vitro investigations. (Neubert et al., 2007)  
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1.9.  Metallic biomaterials clinical application on hard tissue 
In the past few decades, metals have been shown to act like biomaterials 
to assist with the repair or replacement of diseased or damaged hard tissue. 
(Ezechieli et al., 2014; Gepreel & Niinomi, 2013; Staiger et al., 2006; Witte, 2015) 
Nowadays metallic biomaterials such as stainless steel, titanium and cobalt–
chromium-based alloys have been approved and commonly used. Metals are 
more suitable for load-bearing applications due to their combination of high 
mechanical strength and fracture toughness. (Gepreel & Niinomi, 2013; 
Mantripragada, Lecka-Czernik, Ebraheim, & Jayasuriya, 2013).  
Conversely these materials usually are heavy and have the possibility to 
release toxic materials through corrosion or the wear processes, which may then 
lead to inflammation. (Jacobs et al., 1998; Keegan, Learmonth, & Case, 2007; 
Puleo & Huh, 1995) Moreover, the elastic moduli of current metallic biomaterials 
are not well matched with that of natural bone tissue, resulting in stress shielding 
effects that can lead to reduced stimulation of new bone growth and remodeling 
which decreases implant stability. (Nagels, Stokdijk, & Rozing, 2003).  
Also, most of current metallic biomaterials are essentially neutral in vivo, 
remaining as permanent fixtures. For example, plates, screws and pins, which are 
used to secure serious fractures, must be removed by a second surgical 
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procedure, only after the tissue has healed sufficiently. This second surgical 
procedure, however, could easily cause tissue loss. (Henderson et al., 2014; 
Poinern, Brundavanam, & Fawcett, 2012; Puleo & Huh, 1995; Staiger et al., 2006) 
Therefore, magnesium-containing biomaterials were employed, due to 
their advantages such as lightweight, biodegradability, biocompatibility, and 
physical properties such as elastic modulus (Young’s modulus of 37.5–65 GPa). 
and density, which are similar to human bone. At the same time excellent 
osteoconductivity and osteointegration lead to enhanced osteogenic activities of 
cells surrounding the magnesium-containing material (Poinern et al., 2012; P. 
Tian & Liu, 2015; YUAN et al., 2011).   
It is known that magnesium shows also a positive effect on bone density 
and bone absorption parameters both in vitro and in vivo.(Ezechieli et al., 2014; 
Henderson et al., 2014; Kaya et al., 2007; Kwon, Lee, & Hong, 2014; Y. J. Liu, 
Yang, Tan, Li, & Zhang, 2014; Nguyen, Liew, & Liu, 2013; Pichler et al., 2014; 
Song, 2007; Witte et al., 2006; 2005; Yoshizawa, Chaya, Verdelis, Bilodeau, & 
Sfeir, 2015; Zeng et al., 2013; S.-F. Zhao, Jiang, Peel, Wang, & He, 2013). Franks 
at al., even added MgO to glasses and showed a higher proliferation rate of 
human osteosarcoma cells (MG-63) on the modified glass.(Franks, Salih, & 
Knowles, 2002)  
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1.10.  Rationale and clinical significance for this research 
Previous reports of osteogenic effects from magnesium mainly rely on 
studies using ATCC human osteosarcoma cell lines or animal osteoblasts but not 
genuine normal human osteoblasts. From results which our lab already verified 
(Thalanki cite thesis), it has been shown that the osteogenic phenotypes of 
osteosarcoma cell lines are significantly different from normal human osteoblast 
cell lines.(Abed, Martineau, & Moreau, 2011; Cecchinato et al., 2013; H.-K. Kim et 
al., 2016; LÜ, HAN, & JI, 2013; P. Tian, Xu, & Liu, 2016; Tousi et al., 2013; Witte 
et al., 2005; Yoshizawa et al., 2015) Summarizing, osteosarcoma cells proliferate 
significantly more rapidly than normal human osteoblast cells.(Czekanska, 
Stoddart, Richards, & Hayes, 2012; Pautke et al., 2004; Wagner et al., 2011) and 
inversely, the differentiation rate is significantly greater in normal human 
osteoblasts than in any osteosarcoma cell lines tested.(Christenson, 1997; Ortiz, 
Marquez, & Chou, 2010; Robey & Termine, 1985) 
Normally, osteoblast and osteoblast-like cell cultivation requires about 
0.7mM-1.0mM magnesium ions, which is the same as the range of existing 
concentrations in the human body (Alhosaini & Leehey, 2015). Since magnesium 
ions already exists in the human body at a certain concentration, if there were to 
be any further biological effect, most likely these effects would be from the 
presence of higher concentrations of magnesium ions.  
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However, some studies showed that high concentration of magnesium ions 
could cause cell toxicity and suppress differentiation activities (Leidi, Dellera, 
Mariotti, & Maier, 2011; L. Zhang, Yang, Li, Zhu, & Zhang, 2014), indicating that 
the effect of different concentrations of magnesium ions on osteogenesis of 
normal human osteoblasts hasn’t been fully determined yet.(R. W. Li et al., 2014) 
Thus, our objective in this study was to investigate the effect of different 
concentrations of magnesium ions solution on the osteogenesis of normal human 
osteoblasts and to determine the optimal concentration for use in applications of 
magnesium to bone graft materials and scaffolds for bone engineering. 
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2. HYPOTHESIS 
It is hypothesized that supplemented magnesium ions would up-regulate 
normal human osteoblast cells attachment efficiency, cell proliferation and 
osteogenic activity, specifically cell differentiation of normal human osteoblasts.  
The null hypothesis (H0) is that there is no difference in cell attachment 
efficiency, cell proliferation and osteogenic differentiation between the 
experimental sample groups containing supplemented magnesium ions and the 
control group.  
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3. OBJECTIVE OF THE STUDY 
To measure after 16 hours the cellular attachment efficiency of 
pre-osteoblasts cultured on plastic tissue culture plates containing growth media 
with various supplemental Mg2+ concentrations ranging from 0.5 to 16mM and 
compare this to attachment efficiency of cells grown in media without 
supplemental Mg2+ (Control).  
To quantify cellular proliferation rates of pre-osteoblasts grown in culture 
media that contain the same supplemented Mg2+ concentrations as applied for 
objective 1 at following time points 7, 10, 14 and 21 days, and compare those with 
proliferation rates of pre-osteoblasts cultured on growth media with no 
supplemental Mg2+ at the same time points. 
To assess the osteogenic differentiation potential of human osteoblasts 
cultured on differentiation media containing supplemental Mg2+ concentrations as 
mentioned in objective 1 and 2 and compare those to the osteogenic 
differentiation potential of control cells grown on media without supplemental Mg2+ 
for following time intervals: 7, 10, 14 and 21 days. This will be achieved by:  
a) Measuring the enzymatic activity of the secreted tissue non-specific 
alkaline phosphatase in collected tissue cell cultures supernates.  
 32 
b) Measuring the extracellular protein levels of osteocalcin accumulated in 
the collected tissue culture supernates. 
To measure the mineralization of human osteoblasts cultured with 
differentiation media containing the same supplemented concentrations of Mg2+ 
ranging between 0.5 to 16mM at the same time intervals as mentioned before and 
compare to mineralization of control cells. This will be achieved by measuring 
alizarin red stain absorption from cells fixed with formalin and compare to stain 
absorption of control cells. 
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4. MATERIALS AND METHODS 
Table 1: List of materials: 
Material Manufacturer Catalog number 
2 mL pipettes Fisher Scientific 13-678-11C 
10 mL pipettes Fisher Scientific 13-678-11E 
25 mL pipettes Fisher Scientific 13-675-11 
1.5 mL tubes Fisher Scientific 05-408-129 
15 mL centrifuge 
tubes 
Fisher Scientific 14-959-70C 
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50 mL centrifugation 
tubes 
Fisher Scientific 14-432-22 
24 wells tissue 
culture plates 
Celltreat 229123 
60 mm tissue culture 
dishes 
Celltreat 229660 
3x3 weighing paper Fisher Scientific NC9691607 
Aspirating pipettes Fisher Scientific 13-675-16 
Corning 12.5 cm2 
tissue culture flasks 
Fisher Scientific 08-772-1F 
 36 
Corning 225 cm2 
tissue culture flasks 
Fisher Scientific 1482680 
Disposable masks Kimberly-Clark 12978 
Manual pipette P20 Gilson, Pipetman FA10003P 
Manual pipette P100 Gilson, Pipetman FA10004P 
Manual pipette P200 Gilson, Pipetman FA10005P 
Manual pipette P1000 Gilson, Pipetman FA10006P 
Multi tip pipette Brinkman 10N3297 
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Transferpette 20-100 µL 
Multi tip pipette 
Transferpette 50-200 µL 
Brinkman 07R2380 
Pipette tips (blue), 
200- 1000 µL 
Fisher Scientific 21-278-52 
Pipette tips (yellow), 
1- 200 µL 
ENE Mate 1031-800-010 
Pro-pette pipette aid 
(pipette controller) 
MTC Bio P6080 
Scalpel handles Patterson Dental 089-4501 
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Semimicro cuvette Fisher Scientific 14955127 
Surgical Blades #11 HENRY SCHEIN 100-5794 
Thermanox Plastic 
Coverslips, Cell Culture 
treated on one side, 
15mm diameter 
NUNC 174969 
Weighing dish 
(medium) 
Fisher Scientific 02-202-101 
Weighing dish (small) Fisher Scientific 02-202-100 
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Table 2: List of chemicals, enzymes, growth media and kits 
Item Manufacturer Model number 
0.05% Trypsin-EDTA Life Technologies 25300054 
10% Formalin Fisher Scientific HT501128-4L 
70% Ethanol Fisher Scientific S25306A 
Alkaline phosphatase 
assay kit (Fluorometric) 
abcam ab83371 
Alizarin Red S Sigma-Aldrich A3757 
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Beta 
Glycerophosphate 
Sigma G9422 
Calcium Chloride 
(CaCl2) 
Sigma C-3306 
Charcoal stripped FBS Life Technologies 12676011 
Chondroitin sulfate Sigma C-4384 
Collagenase Type I Life Technologies 17100-0 
Crystal Violet, reagent Sigma 229288-100G 
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DMEM/F12 (500mL) Life Technologies 11330057 
Elastase Type I Sigma Aldrich E125-50MG 
Fetal bovine serum Life Technologies 16000044 
Fungizone 
(antifungal) 
Life Technologies 15290-026 
Glutaraldehyde Electron Microscopy 
Sciences 
16220 
Hylcone L-Glutamine Fisher Scientific SH3003401 
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L-ascorbic acid 25g Sigma Aldrich A4544-25G 
Magnesium Chloride  
(MgCl2) 
Sigma BP214-500 
Menadione 25g Sigma Aldrich M5625-25G 
Osteocalcin ELISA kit R&D Technologies DSTCNO 
Pen/Strep 100X Life Technologies 15140-122 
Potassium Chloride 
(KCl) 
Sigma P9541-500g 
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Sodium bicarbonate 
(NaCO3) 
Sigma S5761-500G 
Sodium Chloride 
(NaCl) 
Sigma BP358-212 
Sodium Phosphate 
(Na3SO4) 
Sigma BP332-500 
Vitamin D3 Sigma 1530-10UG 
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Table 3: List of equipment used: 
Item Manufacturer Model number 
360 stirrer VWR Scientific 58935-351 
Biological Safety 
Cabinet 
LABCONCO 3430809 
Centrifuge Marathon 
16KM 
Fisher Scientific 16KM 
Hemocytometer Reichert 26715 
Incubator Thermo ELECTRON 3110 
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CORPORA TION 
Isotemp Waterbath Fisher Scientific 10L-M 
Light microscope 
Leica 
LEITZ DM IL Type: 090-131.002 
Microplate reader 
(spectrophotometer) 
TECAN Infinite 200 Pro 
PH meter with 
electrode 
CORNING 320 
Roto Mix shaker Thermolyne M51335 
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Stirrer CORNING PC-320 
Table Top Centrifuge BECKMAN 340508 
Tissue culture Hood, 
Class II A/B3 Biological 
Safety Cabinet 
Logic 1184 
Touch mixer (tube 
shaker) 
Fisher Scientific 231 
Ultrasonic cleaner Fisher Scientific FS9 
Weight scale DENVER INSTRUMENT P-314 
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Weight scale OHAUS 3113 
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4.1. Approvals and training 
  This study was approved by the Institutional Biosafety committee at Boston 
University (IBC #13-046). All necessary human subject trainings were completed 
through the Collaborative Institutional Training Initiative (CITI). Online lab training 
was provided through the Office of Research at Boston University. Exempt review 
(IRB# H-33173) from the human subjects was granted from the Institutional 
Review Board to use biological waste material of human bone fragments. Patient 
identification from waste human bone is not possible.  
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4.2. Materials 
4.2.1. Agents and cells 
  Isolation of osteogenesis progenitor cells from bone: 
  The procedure to obtain human pre-osteoblast cells was based on a 
previously published protocol with modifications by Robey and Mailot (Mailhot & 
Borke, 1998; Robey & Termine, 1985). Entire Tissue culture isolation and 
maintenance were performed under the class II biological lab safety hood to 
ensure sterile conditions.  
  Human intra-oral bone fragments were obtained through the oral surgery 
department at Boston University School of Dental Medicine. Specimens utilized 
for the experiments were obtained from healthy patients between the ages of 18 
and 50 years old who have no systemic or metabolic bone diseases or acute 
infections, and did not use steroids in the last 6 months before surgery. Bone 
samples were obtained from discarded bone tissue during dental teeth extraction 
and other ostectomy procedures. Once the bone samples were collected, they 
were stored in a tube containing 1 x PBS solution (Gibco). Then they were 
immediately transported in a spill safe container to the lab for processing within 
one hour.  
 50 
First, using a sterile surgical blade (Henry Schein) the soft tissue attached on 
bone was removed. Most of the obtained bone fragments had a length ranging 
from 5 to 8 mm. Using a sterile micro dissecting scissor() and #11 surgical blade, 
bone fragments were cut into 2-4 mm small pieces to increase the contact surface 
of the bone to the culture flask.  
The small pieces of bone tissue were then treated with an enzyme cocktail in a 
1X Kreb’s solution. The enzyme cocktail is a mixture of Collagenase I (3mg/mL), 
Elastase Type I (6.25 U/mL), Chondroitin sulfate (6 mg/mL), D-Sorbitol (18.22 
mg/mL) and Penicillin (100U/mL). The Kreb’s solution was composed from the 
following chemicals: 126mM NaCl, 2.5mM KCl, 25mM NaHCO3, 1.2mM NaH2PO4, 
1.2mM MgCl2, and 2.5mM CaCl2 the pH value was adjusted to 7.2 and the 
solution was sterile filtered.  
The bone fragments in the enzyme cocktail solution were then incubated in a 
water bath at 37°C for 20 min, the procedure repeated twice to achieve best 
enzymatic reaction effect. After the water bath, by adding 5 mL of the culture 
media [10% fetal bovine serum FBS (Atlanta Biologicals) and 
1XPenicillin/Streptomycin (Gibco) in DMEM/F12 (1:1)] into the tube which 
contained the bone fragments blocked the enzymatic reaction. Then, the tube was 
centrifuged with 1000 rpm at room temperature (RT) for 5 minutes. When the 
centrifugation process was done, the mixture of enzyme cocktail and culture 
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media was removed by aspiration. Finally the bone fragments were washed with 
1X PBS.  
After the enzymatic digestion of the soft tissue and fibroblasts, bone fragments 
were cultured in a 12.5 cm2 flask containing 6 mL growth media [ 10% fetal bovine 
serum (FBS), 1X Penicillin/Streptomycin antibiotic (100 U/mL), Amphotericin B 
anti-fungal (2.5mg/ml) in Dulbecco’s Modified Eagle Medium (DMEM)]. The bone 
fragments were maintained at 37°C, in a standard CO2 incubator (5% carbon 
dioxide, and saturated humidity). Bone fragments were kept in the flask for the 
first 7-10 days to allow cell migration from the bone and attaching to the flask 
surface. After that time, bone fragments were removed from the flask and 
discarded to allow the attached cells to have more space to grow on the flask 
surface and reduce the risk of microbial contamination. 
Primary cell culture cells in the 12.5 cm2 size flask grew for about 3-4 weeks to 
reach 70-80% confluence. Growth media was changed every day for a total of 10 
days, followed by media changes every 72 hours thereafter. The process of 
media change was as follows; first the old growth media was aspirated, then the 
bone fragments were washed with 10 mL of 1X PBS and finally the 1x PBS was 
aspirated. Lastly, 6 mL of new growth media was added. The cell number after 
almost a month was then sufficient for transfer to a larger tissue culture flask.  
 52 
4.2.2. Tissue culture maintenance and expansion 
  When cells reached a 70-80% confluence in the small 12.5 cm2 flask, media 
was aspirated, followed by rinsing with 1X PBS and PBS removal. Then, using 1 
mL of 0.05% Trypsin EDTA for 2-3 minutes at 37°C, the attached cells in the 12.5 
cm2 flask were detached in order to transfer them to a large 225 cm2 flask for the 
secondary cell culture expansion. After ensuring of complete cell detachment 
from the flask surface using the light microscope, 10 mL of DMEM/F12 media was 
added blocking the trypsin activity. The cells re-suspended in the media were then 
collected in a sterile 15 mL disposable tube for centrifugation for 5 minutes with 
1000 rpm at RT. When the cell pellet in the bottom of the tube was formed after 
centrifugation, the solution above the pellet containing the trypsin was carefully 
aspirated.  
Cells were washed once more with 1x PBS to remove any remaining enzyme 
traces and finally cells were re-suspended in 10ml fresh media and were then 
transferred in a new 225cm2 flask containing additional 50mL of growth media. 
Same as for primary cell culture, the growth media was changed every day for the 
first 10 days, and then was changed every 72 hours until the cells reach enough 
confluence; this secondary cell culture took about 2-3 weeks to reach a 70-80% 
confluence. The total volume of growth media required for the big flask is 60 ml 
and plates were washed with 20 ml PBS whenever change the new media. 
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4.2.3. Determination of the optimal cell seeding concentration 
  A pilot study was done to determine the optimal cell seeding concentration 
for normal human osteoblasts in a 24 well culture plate for 21 days. This was 
essential to ensure that during that time, no cell death occurs, which would 
undermine the experimental outcome. This was achieved through testing various 
seeding cell concentrations on 24 wells culture plates: 5x104, 1x104, 3x104, 5x103, 
3 x103 and 1x103. All cell seeding conditions were tested at least in triplicate wells 
to ensure statistical significance. Cells were monitored daily using a light 
microscope. Additionally after 7, 14 and 21 days, absorbance of crystal violet 
stained cells was recorded using a microplate reader. It was then determined that 
the optimal seeding concentration for the proliferation and differentiation 
experiments to reach 21 days is 3x103 cells, since no cell death occurred in 21 
days. 
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4.2.4. Attachment efficiency assay 
  This experiment was conducted to measure the efficiency of osteoblast 
attachment on plastic (surface of tissue culture dishes) when treat with various 
concentrations of supplemented magnesium ion compared to control (no 
additional magnesium ion). To measure attachment efficiency 1x106 cells were 
seeded on multiple tissue culture dishes and at different time intervals of 3 hours, 
6 hours, 9 hours, 12 hours and 16 hours, the supernates from each plate were 
collected in disposable tubes. This supernates contained floating non-attached 
cells, that was added to the Rechert-Jung hemocytometer and the number of 
living cells counted on the grid was recorded. The number of cells counted was 
subtracted from that originally seeded cell number (1x106) and the calculated 
number was converted the number to a percentage by dividing the two numbers 
and multiplying by 100. This gives us the estimated number of cells attached.  
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4.2.5. Proliferation rates by Crystal Violet stain 
Adherent cells detach from cell culture plates during cell death. This 
characteristic can be used for determination of differences in proliferation upon 
stimulation with death-inducing agents. Simply, cells that undergo cell death lose 
their adherence and are subsequently lost from the population of cells, removed 
by 1x PBS washes, reducing the amount of crystal violet staining absorbed by the 
tissue culture. Crystal violet stain has been applied to determine proliferation rates. 
Depending on the amount of dye taken up by the monolayer of cells attached on a 
surface, a relative optical density is quantified using a spectrophotometer.  
Initially, three thousand cells were seeded in 24-wells containing 1 mL growth 
media or growth media with various supplemental MgCl2 concentrations. Each 
condition has been triplicated and growth medium with or without MgCl2 
supplements was changed every 3 days. The culture plates were incubated under 
37°C and 5% CO2 for following time points: 7 days, 10 days, 14 days and 21 days. 
Cell proliferation was determined at time points of 7, 10, 14 and 21 days. 
At each required time point, growth medium was removed and cells were fixed 
with 10% neutral buffered formalin (Sigma) for one hour at room temperature. 
Fixer solution was then removed, plates were washed twice with 1x PBS and then 
stained with 1 ml 0.2% crystal violet stain (Sigma Aldrich) for 1hr at room 
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temperature. Unbound stain was removed by rinsing plates thoroughly with 
deionized water until clear.  
Then optical density value was measured by microplate reader (TECAN, 
Infinite 200 Pro) at 590nm wavelength. Absorbance of crystal violet is directly 
proportional to cell numbers. Three measurements were performed and mean cell 
numbers were calculated. 
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4.2.6. Alkaline phosphatase assay kit 
  The fluorometric alkaline phosphatase assay kit was employed to measure 
alkaline phosphatase activity in cell culture supernates. This kit is an 
ultra-sensitive, direct and HTS-ready assay designed to measure ALP activity in 
serum and bio-samples with detection sensitivity ~1µU, more sensitive than 
colorimetric assays.  
The alkaline phosphatase enzyme was secreted in media in the early stages 
of differentiation, upon stimulation with well-defined differentiation media. In its 
active form, the enzyme catalyzes the hydrolysis of phosphate esters in alkaline 
conditions. Secreted active functional alkaline phosphatase enzyme in the 
supernates cleaved the phosphate group of the non-fluorescent 
4-methylumbelliferyl phosphate disodium salt (MUP) substrate provided by the kit 
resulting in an intense fluorescent signal. 
The ALP activity was measured according to the manufacturer’s instructions. 
For each condition three samples were employed. Exactly 100µL culture 
supernates were incubated with 20µL the non-fluorescent 4-methylumbelliferone 
phosphatase disodium salt (MUP) substrate; MUP was converted to the 
fluorescent 4-methylumbelliferone when dephospholated by active secreted ALP. 
After incubation for 30 minutes at 25oC in the dark, the reaction was stopped with 
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20µL stop solution by gentle shaking of the plate. The emission was measured at 
440nm by excitation at 360 nm on a microplate reader (TECAN, Infinite 200 Pro). 
Three measurements for each value were performed for averaging and alkaline 
phosphatase activities were calculated by a standard curve. 
Standard curve was created as follows: 
A 50µM MUP standard solution was prepared by diluting 5µL of the 5mM MUP 
substrate (standard) with 495µL Assay Buffer. Standard curve dilutions as 
described in the table 4. were prepared and added duplicated into the 96 wells 
plate, each dilution has enough amount of standard to set up duplicate readings 
(2 x 120µL).: 
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Standard #  
Volume of 
Standard (µL)  
Assay Buffer 
(µL)  
Final volume 
standard in 
well (µL)  
End [MUP] in 
well  
1  0  360  120  0nmol/well  
2  6  354  120  0.1nmol/well  
3  12  348  120  0.2nmol/well  
4  18  342  120  0.3nmol/well  
5  24  336  120  0.4nmol/well  
6  30  330  120  0.5nmol/well  
Table 4. Preparation volumes of standard curve dilutions for ALP assay 
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After triplicated reading of absorbance for all the standard curve dilutions 
and subtraction of the mean of the absorbance value of the blank, the corrected 
absorbance values for each standard as a function of the final concentration of 
4-MU was plotted. The best smooth curve through these points to construct the 
standard curve was drawn with an R value higher than 0.99. Same protocol was 
utilized later to the sample readings to achieve the corrected absorbance. Sample 
readings were applied to the standard curve to get the amount of 4-MU generated 
by ALP sample. 
Concentration (mU/mL) of alkaline phosphatase in the test samples is 
calculated as: 
ALP activity = B/(V/T) * D, where B is amount of 4-MU generated by 
samples (in nmol), V is volume of sample added in the assay well (in mL), T is 
reaction time (in minutes) and D is the sample dilution factor. 
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4.2.7. Osteocalcin ELISA assay 
  Osteocalcin is a protein that is expressed and released from bone during 
late differentiation. In order to measure osteocalcin released in osteoblast cell 
cultures supernates, a competitive human osteocalcin immunoassay (Quantikine 
ELISA) was employed. The kit is a 4.5 hour solid-phase ELISA assay and 
employs a monoclonal antibody that is specific for human osteocalcin and is 
pre-coated onto a 96 well microplate provided. It contains also an 
Osteocalcin-HRP conjugate,that binds to human osteocalcin protein, making 
osteocalcin amounts detectable.  
To begin with the assay, we reconstituted the wash buffer by adding 20 mL 
of warm wash buffer concentrate to deionized or distilled water and gently mixing 
to prepare 500 mL wash buffer. The substrate solution was prepared by mixing 
equal volumes of color reagents A and B. This solution should be protect from 
light and could be utilized within 15 minutes after prepraration. The calibrator 
diluent RD6-67 (diluted 1:5) solution was prepared by adding 4mL of Calibrator 
Diluent RD6-67 to 16 mL of deionized or distilled water. 
Following the manufacturer’s instructions, 50µL samples plus 100µL Assay 
Diluent RD1-117 were pipetted into each well of the microplate. Triplicate samples 
from each condition were always included.  
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Standard samples were also added as described by the manufacturer. 
Initially the Human Osteocalcin Standard was reconstituted with deionized or 
distilled water. This reconstitution produced a stock solution of 128ng/mL. The 
standard was well mixed for 15 minutes with gentle agitation to ensure complete 
reconstitution. Then 300µL of Calibrator Diluent RD6-67 (diluted 1:5) was added 
into each tube. Dilutions series were produced by using the stock solution adding 
Calibrator Diluanet RD6-67 as described in the table 5. 
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Standard # 
Volume of 
Standard (µL) 
Calibrator 
Diluent 
RD6-67 (µL) 
Final volume 
standard in 
well (µL) 
End 
concentration 
in well 
1 300 300 50 64ng/mL 
2 
300 of 
Standard #1 
300 50 32ng/mL 
3 
300 of 
Standard #2 
300 50 16ng/mL 
4 
300 of 
Standard #3 
300 50 8ng/mL 
5 
300 of 
Standard #4 
300 50 4ng/mL 
6 
300 of 
Standard #5 
300 50 2ng/mL 
Table 5. Preparation volumes of standard curve dilutions for osteocalcin 
ELISA assay 
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Each tube was thoroughly mixed before the next transfer. The 64ng/mL 
standard served as the high standard and the appropriate Calibrator Diluent 
served as the zero standard (0ng/mL). 
Plates were incubated for 2 hours with shaking on a horizontal orbital 
shaker. After the incubation period, all wells were decanted and washed four 
times. Then wells were further incubated with 200µL of Human Osteocalcin-HRP 
Conjugate for 2 more hours at RT by shaking. After decanting and washing the 
wells, 200µL of HRP substrate was added and incubated in the dark for 30 
minutes at RT. The substrate turns blue in presence of human osteocalcin and 
HRP conjugate. Finally, stop solution was added, which turned the solution color 
from blue to yellow. The intensity of the solution color was then measured 
spectrophotometrically at 450 nm in a micro-plate reader and was inversely 
proportional to the concentration of the osteocalcin present in the samples. Three 
measurements were performed for averaging and Osteocalcin concentrations 
were calculated by a standard curve.  
The standard curve was created by the follows: 
First of all, the average zero standard optical density was subtracted from 
all values. Then a standard curve was created by plotting the mean absorbance 
for each standard on the y-axis against the concentration on the x-axis, the best-fit 
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curve was drawn through the points on a log/log graph. The data was linearized 
by plotting the log of the human Osteocalcin concentrations versus the log of the 
O.D. on a linear scale, and the best fit line was determined by regression analysis.  
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4.2.8. Mineralization assay by Alizarin Red S Staining 
Alizarin Red S (ARS), an anthraquinone dye, has been widely used to 
evaluate calcium deposits in cell culture, which is a sensitive tool for the recovery 
and semi-quantification of ARS in a stained monolayer of cells. Mineralization is 
assessed by extraction of calcified mineral at low pH, neutralization with 
ammonium hydroxide, and colorimetric detection at 405 nm. This assay is more 
sensitive than the cetylpyridinium chloride (CPC) extraction method, improving 
the detection of weakly mineralizing monolayers. 
Alizarin Red S staining solution was prepared by dissolving 2 g Alizarin 
Red S in 100 ml distilled water, mixing, and adjusting pH to 4.1 - 4.3 with 0.1% 
NH4OH. The dark-brown solution was filtered and stored it in the dark until use 
within a month. 24 wells culture plates were taken from the incubator and medium 
was aspirated. Cells were washed twice with DPBS. Under the fume hood, the 
PBS was aspirated and 1mL neutral buffered formalin (10%) was added to cover 
the cellular monolayer. After 60minutes incubation at RT. Formalin was aspirated 
and the fixed cells were washed twice with distilled water. 
Finally, after removal of the distilled water, Alizarin Red S staining solution 
was added to the cellular monolayer. Cells were incubated at room temperature in 
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the dark for 45min. Then the Alizarin Red S staining solution was removed and 
the monolayer was washed four times with 1ml distilled water.  
Absorbance at 405nm was measured three times by a microplate reader 
and stained background was subtracted from each sample.  
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5. STATISTICAL ANALYSIS 
  All experiments were performed in triplicate and repeated three times. 
Data are presented in means and standard deviations. The means and standard 
deviations (SD) of osteoblast cell attachment and proliferation percentages at 16 
hours, 7,10, 14 and 21 days were calculated, in addition to levels of osteogenic 
differentiation markers (Alkaline phosphatase and Osteocalcin) and mineralization 
at the same timelines. Differentiation and mineralization data has been 
normalized on a per million cells basis by the number of cells counted at 7, 10, 14, 
21 days.    
  Statistical analysis was performed using software JMP Pro 12 (ver. 
12.1.0) in Student’s t-test to detect the statistical differences between the groups. 
Differences at p ≤ 0.05 were considered statistically significant.  
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6. RESULTS 
6.1. Attachment efficiency 
  Adherence of cells on cell culture wells occurred within a few hours after 
cells were seeded. Pre-osteoblast cells attachment on standard tissue culture 
dish surfaces with a diameter of 60 mm was measured at different time intervals 
from the time of seeding. Theses time points were 3, 6, 9, 12 and 16 hours. Each 
plate per timeline was measured. A hemocytometer was used to count the floating 
cells and that value was subtracted from the seeding cell concentration 1x106. 
Then, the percentage of attached cells was calculated by dividing the number of 
cells counted at each timeline by the total number of cells seeded. Attachment 
efficiency was calculated to establish a baseline on normal behavior of human 
osteoblasts in second passage of cell culture. Data are presented in the table 
below (Table 6.). 
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Time interval Osteoblast cells attachment 
efficiency 
3 hours 93.25% 
6 hours 96.79% 
9 hours 98.38% 
12 hours 98.5% 
16 hours 98.91% 
Table 6. Data representing osteoblast cells attachment efficiency at different 
time intervals from 3 hours to 16 hours cultured on tissue culture dishes. (n=3) 
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  To detect if addition of supplemented magnesium ion in the culture 
medium was affecting cellular attachment, three thousands normal human 
osteoblasts were cultured in 24 well plates containing culture media 
supplemented with different magnesium ion concentrations, ranging from 0.5 to 
16mM, for a time period of 16 hours.  
  It has been observed that within this time period, no cell doubling occurs. 
Therefore, possible cell number changes are attributed only to the ability of 
osteoblasts to attach on culture wells when grown in culture media containing 
different magnesium ion concentrations.  
  Cell attachment efficiency was not significantly affected by any 
magnesium ion concentration tested in this experiment when compared to the 
control containing culture media without supplemental magnesium ion. The 
differences are not statistically significant indicating that the seeded cell number is 
invariably similar between the different groups and the control (Figure 1.). 
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Cell attachment efficiency at 16 hours (n=3) 
 
Figure 1. Normal human osteoblasts were cultured for 16 hours with media 
containing supplemental Mg2+ ranging from 0.5 to 16mM. The control cells were 
treated with growth media without supplemental Mg2+. No significant difference 
was observed compared to the control in each condition (p>0.05).  
Error bars indicate the standard deviations of three replicates. 
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6.2. Proliferation rate affected by Mg2+ at various concentrations 
  To identify the effects of Mg2+ on cell behavior, the same numbers of 
normal human osteoblasts were cultured in 24 well plates containing culture 
media supplemented with various Mg2+ concentrations. Cell numbers were 
determined at days 7, 10, 14 and 21 by using the optical density values measured 
from the spectrophotometer, values were converted to cell number. The ratio of 
cellular crystal violet stain to cell number has been determined from the known 
seeding cell numbers in plates and measuring the corresponding dye stain from 
those plates three times using the same and different seeding numbers of cells. 
The ratio has been consistent and reproducible for all those measurements and 
therefore, it could be used to convert the optical density dye data to cell numbers 
with confidence. 
  Initially when osteoblasts proliferated at 7 days (Figure 2.), a significant 
cell number increase was observed only in the low Mg2+ groups, between 
0.5mM-4mM (p<0.05). The three remaining groups that grew in media containing 
high Mg2+ concentrations, 8mM and above behaved similar to the control cells 
grown on culture media without supplements (p>0.05).  
  At 10 days (Figure 3.) the 2, 4 and 8mM Mg2+-containing groups 
proliferated faster than the control group (p<0.05), indicating that a higher Mg2+ 
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concentration could be beneficial for osteoblast growth, however not without 
limitations. The 16mM sample group containing the highest Mg2+ concentration 
tested in this experiment did not proliferate fast as did the 2,4 and 8mM groups 
but rather behaved similar to the control group (p>0.05).  
  Interestingly, on the 14th day (Figure 4.), only the 2 and 4mM Mg2+ 
groups still showed enhanced proliferation (p<0.05). At this time period, the 16mM 
group significantly reduced proliferation (p<0.05).  In the last proliferation period, 
Day 21 (Figure 5.), the low Mg2+ groups (up to 2mM) increased (p<0.05) and the 
16mM high Mg2+ group significantly decreased growth (p<0.05). 
  The trend of the affected results during the whole assay could be seen in 
(Figure 6.), which present the proliferation of normal human osteoblast cells with 
various supplemental Mg2+ in folds, which were calculated by dividing the cell 
numbers at each time interval by the seeded cell numbers for each condition. 
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Cell proliferation at 7 days (n=3) 
 
Figure 2. Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time period of 7 
days. Cell number was calculated by using optical density measurement results 
dividing the constant number (per cell’s optical density). The control cells were 
treated with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Cell proliferation at 10 days (n=3) 
 
Figure 3. Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time period of 10 
days. Cell number was calculated by using optical density measurement results 
dividing the constant number (per cell’s optical density). The control cells were 
treated with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Cell proliferation at 14 days (n=3) 
 
Figure 4. Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time period of 14 
days. Cell number was calculated by using optical density measurement results 
dividing the constant number (per cell’s optical density). The control cells were 
treated with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Cell proliferation at 21 days (n=3) 
 
Figure 5. Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time period of 21 
days. Cell number was calculated by using optical density measurement results 
dividing the constant number (per cell’s optical density). The control cells were 
treated with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
 
 81 
Comparison of cell proliferation at different time intervals (n=3) 
 
Figure 6. Proliferation of normal human osteoblasts in media supplemented 
with various Mg2+ concentrations ranging from 0.5 to 16mM for a time period of 7, 
10, 14 and 21 days. Folds were calculated by dividing the cell numbers at each 
time interval by the seeded cell numbers for each condition. The control cells were 
treated with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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6.3. ALP activity affected by Mg2+ at various concentrations 
Results observed at day 7 (Figure 7.), ALP activity for most groups 
tested was comparable to the control with no significant differences among 
those groups. However, significant increase in enzymatic activity was observed 
when 2mM Mg2+ was added to the growth media and significant decrease was 
recorded in 16mM group. 
At day 10 (Figure 8.), the same group showed an even higher activity 
that continued at day 14 (Figure 9.) and reached the highest value at day 21 
(Figure 10.), with nearly a 1.4 fold increase detected. Moreover, at day 10 an 
increase in ALP activity was observed in the group supplemented with 1mM 
Mg2+ compared to the control. It was statistically significant as well for day 14 
and day 21. The highest increase was measured on day 21, and is 1.53 fold 
higher than the control. Data revealed that Mg2+ concentrations in the range of 
1-2mM have the highest effect on ALP activity.  
Cells grown in media containing the highest Mg2+ supplements (16mM) 
demonstrated significantly the lower ALP activity compared to the control in all 
time periods tested. There was also a decreased activity observed in the 8mM 
Mg2+ containing group, which is statistically significant for days 10,14 and 21. 
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The comparison of different time interval in the whole assay could be 
appreciated in (Fig 11.), which could clearly shoed the increasing of alkaline 
phosphatase activities of normal human osteoblast cells with various 
supplemental Mg2+, the data were normalized per million cells at each time 
interval. 
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Alkaline phosphatase activity at 7 days (n=3) 
 
Figure 7. Alkaline phosphatase activity of normal human osteoblasts in 
media supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7 days. Alkaline phosphatase activity in supernates 
was normalized per million cells at each time interval. The control cells were 
treated with growth media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Alkaline phosphatase activity at 10 days (n=3) 
 
Figure 8. Alkaline phosphatase activity of normal human osteoblasts in 
media supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 10 days. Alkaline phosphatase activity in supernates 
was normalized per million cells at each time interval. The control cells were 
treated with growth media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Alkaline phosphatase activity at 14 days (n=3) 
 
Figure 9. Alkaline phosphatase activity of normal human osteoblasts in 
media supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 14 days. Alkaline phosphatase activity in supernates 
was normalized per million cells at each time interval. The control cells were 
treated with growth media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Alkaline phosphatase activity at 21 days (n=3) 
 
Figure 10. Alkaline phosphatase activity of normal human osteoblasts in 
media supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 21 days. Alkaline phosphatase activity in supernates 
was normalized per million cells at each time interval. The control cells were 
treated with growth media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Comparison of ALP activity at different time intervals (n=3) 
 
Figure 11. Alkaline phosphatase activity of normal human osteoblasts in 
media supplemented with various Mg2+ concentrations ranging from 0.5 to 
16mM for a time period of 7, 10, 14 and 21 days. Alkaline phosphatase activity 
in supernates was normalized per million cells at each time interval. The control 
cells were treated with growth media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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6.4. Osteocalcin expression affected by Mg2+ at various concentrations 
Osteocalcin expression is an indicator of osteogenic differentiation. The 
highest value of osteocalcin produced on day 7 was derived from cells exposed 
to supplemental 2mM Mg2+ (Figure 12.). Protein production in the 1mM group 
was also significantly increased, with values slightly lower than the ones 
derived from the 2mM group.  
The same tendency was revealed at day 10 (Fig 13.) and day 14 (Fig 
14.). On day 14, the highest Mg2+ concentration exhibited reduced osteocalcin 
protein expression when compared to the control. The same trend continued 
also on day 21 (Fig 15.), where the concentration of 8mM was causing a 
negative effect.  
Overall, osteocalcin expression was significantly increased on day 21 
compared to its expression on day 7, which could be seen in (Fig 16.). The 
highest osteocalcin amount measured on day 21 was expressed by the 2mM 
Mg2+ group. The protein amount is 3.59 fold compared to the quantity of the 
same group on day 7.  
The data on day 21 are similar to the ones observed for the same time 
period for Alkaline phosphatase activity, indicating once more that addition of 
 90 
Mg2+ to culture media up to 2mM is sufficient to increase osteogenic 
differentiation and values 8mM and above inhibit the differentiation process.  
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Osteocalcin expression at 7 days (n=3) 
 
Figure 12. Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7 days. Osteocalcin expression in supernates was normalized 
per million cells at each time interval. The control cells were treated with growth 
media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Osteocalcin expression at 10 days (n=3) 
 
Figure 13. Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 10 days. Osteocalcin expression in supernates was normalized 
per million cells at each time interval. The control cells were treated with growth 
media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Osteocalcin expression at 14 days (n=3) 
 
Figure 14. Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 14 days. Osteocalcin expression in supernates was normalized 
per million cells at each time interval. The control cells were treated with growth 
media without supplemental Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Osteocalcin expression at 21 days (n=3) 
 
Figure 15. Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 21 days. Osteocalcin expression in supernates was normalized 
per million cells at each time interval. The control cells were treated with growth 
media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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Comparison of osteocalcin expression at different time intervals (n=3) 
 
Figure 16. Osteocalcin expression of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7, 10, 14 and 21 days. Osteocalcin expression in supernates was 
normalized per million cells at each time interval. The control cells were treated 
with growth media without supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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6.5. Mineralization affected by Mg2+ at various concentrations 
 Multiple biomarkers during osteoblast differentiation had significantly 
increased expression in previous studies. Mineralization of differentiating 
osteoblasts was measured by Alizarin Red S staining. At day 7, the degree of 
mineralization recorded is highest in the control group (Figure 17.). 
  However, at day 10, data from the 1-4mM groups presented higher 
mineralization when compared to the control (Figure 18.). The increase also 
could be observed at day 14 (Figure 19.); groups 0.5-2mM mineralized better 
than other sample groups.  
  Eventually at day 21, 1mM and 2mM up-regulated osteoblast mineralization 
while 4mM and 8mM groups down regulated the calcium deposition (Figure 20.), 
and to conclude the whole assay, (Fig 21.) illustrates the results during different 
time intervals. 
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Mineralization at 7 days (n=3) 
 
Figure 17. Mineralization of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7 days. Mineralization of fixed cell samples was measured by 
spectroscopic analysis at 405nm and normalized per million cells at each time 
interval. The control cells were treated with growth media without supplemental 
Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates.  
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Mineralization at 10 days (n=3) 
 
Figure 18. Mineralization of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 10 days. Mineralization of fixed cell samples was measured by 
spectroscopic analysis at 405nm and normalized per million cells at each time 
interval. The control cells were treated with growth media without supplemental 
Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates.  
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Mineralization at 14 days (n=3) 
 
Figure 19. Mineralization of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 14 days. Mineralization of fixed cell samples was measured by 
spectroscopic analysis at 405nm and normalized per million cells at each time 
interval. The control cells were treated with growth media without supplemental 
Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates.  
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Mineralization at 21 days (n=3) 
 
Figure 20. Mineralization of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 21 days. Mineralization of fixed cell samples was measured by 
spectroscopic analysis at 405nm and normalized per million cells at each time 
interval. The control cells were treated with growth media without supplemental 
Mg2+. 
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates.  
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Comparison of mineralization at different time intervals (n=3) 
 
Figure 21. Mineralization of normal human osteoblasts in media 
supplemented with various Mg2+ concentrations ranging from 0.5 to 16mM for a 
time period of 7, 10, 14 and 21 days. Mineralization of fixed cell samples was 
measured by spectroscopic analysis at 405nm and normalized per million cells 
at each time interval. The control cells were treated with growth media without 
supplemental Mg2+.  
*Significant difference (p<0.05) compared to all groups at the specified time 
point. Error bars indicate the standard deviations of three replicates. 
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7.DISCUSSION 
The aim of the present study was to evaluate the osteogenic effect of 
various concentrations of supplemented Mg2+ on normal human osteoblasts. 
Some studies revealed that in human mesenchymal stem cells, higher Mg 
concentrations induced an osteogenic effect in respect to gene expression (Leem 
et al., 2014; Yoshizawa, Brown, Barchowsky, & Sfeir, 2014). Data from this study 
on normal human osteoblasts were more clinically relevant compared to data from 
previous studies, which utilized ATCC malignant cell lines and animal osteoblast 
cell lines. With this purpose, experiments of cell attachment efficiency, 
proliferation rate, alkaline phosphatase activity, osteocalcin expression and 
mineralization were investigated.  
In the past, various groups used osteosarcoma cells to evaluate the 
biological effect of Magnesium in bone forming cells. For example in 2002, Franks 
et al utilized the human osteosarcoma cell line MG-63 to find out if Mg extract 
could up-regulate cell proliferation up to 5 days of culture. Extracts from bio-glass 
containing different amounts of MgO were employed for this study. High 
proliferation rates were observed after 2 days with extract dilutions containing 
17mol% Mg, however higher proliferation rates were observed after 5 days in 
extracts with Mg content of 22mol%. Obviously increased magnesium ion 
concentration in glass extracts increased also proliferation over time. Bio-glass 
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extracts with MgO concentration up to 7mol%, did not affect much the 5 days 
proliferation when compared to control rates of non-treated 
osteosarcomas.(Franks et al., 2002)  
However, in Burmester’s study (Burmester, Willumeit-Römer, & 
Feyerabend, 2015), Mg2+extracts from implant material caused no significant 
proliferation change on the same osteosarcaome line MG63 cells as well as on 
U2OS, whereas proliferation rates increased for human osteoblasts and 
decreased for SaoS2. Similarly, our studies on normal human osteoblast 
proliferation revealed the same proliferative effect.  The positively influenced 
proliferation caused either by extract addition or directly by magnesium salt to the 
cells may serve as first indicator of the osteoinductive properties of Magnesium in 
primary human osteoblasts.  
Similarly to our studies, the same group revealed that magnesium extracts 
on human osteoblasts, upregulated several genes involved in bone formation. On 
the other hand, the results from the non primary cell lines were inhomogeneous 
and showed no specific stimulus of Mg. Specifically, the addition of Mg-based 
extracts for 1 week led to an increased gene expression for almost all examined 
genes in primary human osteoblasts. In both studies, ours and theirs, ALP was 
used as an early marker for pre-osteoblasts and Osteocalcin as a marker for 
mature osteoblasts, which are prone to produce matrix. Again in Burmeister’s 
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study, an increase in ALP indicated induction of osteoblast maturation. This was 
the case for cells after 2 weeks of extract addition in differentiation media. 
Similarly, in our study exposure of Mg to human osteoblasts induced a significant 
increase for both markers. This behavior again indicated osteoinductive 
properties of Magnesium. In the same study, adhesion strength was evaluated as 
well, quantifying distrubution of focal adhesion for primary human osteoblasts 
growing on plastic and comparing with those exposed with Mg extracts. Surprising, 
the amount of focal adhesions decreased over time, although proliferation rate 
increases. It is widely accepted though, that decrease of focal adhesions causes 
cells to reduce proliferation as well. 
Tousi utilized glass conditioned mediums (GCMs) containing 0.4mM of 
each individual ion treatment of Si4+, Mg2+ and Ca2+, combination treatment at 
0.8mM at a 1:1 ratio of Si4+: Mg2+, Ca2+: Mg2+, or Si2+: Ca2+ on mouse cell line 
MC3T3-E1 to test the osteoblast osteocalcin expression. They found that the 
presence of Mg2+ either individually down-regulated OCN expression or 
combinatorially limited Si4+ or Ca2+ up-regulation of OCN expression (Tousi et al., 
2013), which is different from the results we utilized normal human osteoblast.  
Moreover, Park(Park et al., 2013) discovered that Mg2+ coating on 
titanium surfaces increased cell proliferation of MC3T3-E1 slightly but not 
significant when compared to cells grown on non coated titanium. The same cell 
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population showed 50-60% higher ALP expression levels and higher levels of 
osteocalcin mRNA expression as well, similar to our data. 
Taking all the results together, the comparison of the investigated cell lines 
with primary human OB under the examined conditions demonstrated that the cell 
types exhibit varying characteristics and behaviors. Therefore, a suitable cell 
model to avoid the disadvantages of OB has to be carefully chosen. In this study, 
no cell line is comparable regarding proliferation. Regarding cell size, SaoS2 
could be a model for adhered cells. For extract supplementation and gene 
expression, none of the investigated cell line is suitable. If direct contact is 
examined, U2OS could be used as a model. Again, it turned out that MG63, which 
are often used as an OB model, showed a completely different behavior than 
primary osteoblasts if Mg is examined.  
In conclusion, the results varied between different osteoblast cell lines and 
none of them tested all properties of proliferation and differentiation in the same 
experiment, nor in the normal human cell models. This finding proves that the 
current study could be valuable to understand the comprehensive osteogenesis 
effect of Mg2+ on normal human osteoblast. 
Recently, He et al.(L. Y. He, Zhang, Liu, Tian, & Ma, 2016) showed that a 
higher concentration of Mg2+ has a positive effect on the hFOB1.19 cell line, 
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which is a SV40 large T antigen transfected cell line and therefore does not 
behave like a normal osteoblast cell line. Nonetheless in this study the osteogenic 
differentiation effect was only investigated for 72 hours. However, the 72 hours 
are not sufficient for any osteogenic differentiation study conclusion has been 
shown by Kulterer (Kulterer et al., 2007). In a study he performed using a 
microarray assay he analyzed the expression profiles of genes involved in 
osteogenic development on human mesenchymal stem cells in order to disclose 
possible alterations during a three weeks ex vivo expansion. Based on his data, 
the duration of the proliferation phase lasts about 4-5 days, the matrix maturation 
phase including differentiation starts on day 5 after induction and finishes around 
day15, a conclusion which make the previously mentioned findings of He 
irrelevant. Expression of differentiation biomarkers such as alkaline phosphatase 
and osteocalcin has been recorded within that time and not in the first 72 hours as 
claimed in the He’s study. In addition the same study has one more limitation. The 
tested supplemented 1mM-3mM Mg2+ dose range in the He’s study was very 
narrow, therefore the proliferative effect of the 4mM supplemented Mg2+ to 
normal human osteoblasts was overlooked. 
Lü et al. utilized extracellular supplemented Mg2+ raging 0mM to 120mM 
to test the osteogenic effect on normal rabbit osteoblasts (LÜ et al., 2013). A 
concentration up to 70mM supplemented Mg2+ could up-regulate proliferation but 
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the most effective concentration was determined to be 30mM, which is not 
agreement with our results. A possible explanation for the high dose of 
magnesium in this experiment is maybe a higher Mg2+ tolerance for normal rabbit 
osteoblasts, which appear to be higher than the magnesium tolerance for normal 
human osteoblasts. A magnesium concentration over 4mM did not only inhibit the 
proliferation activity but could possibly also induce cytotoxic effects on normal 
human osteoblast cells, so the data from Lü can't be used to human clinic 
application. 
Wu et al. tested cell proliferation and differentiation of osteoblast and 
osteoclast cocultures exposed to seven dilutions of Mg extract and various time 
points identical to the time points chosen in our study. In that study, lactate 
dehydrogenase activity revealed a gradual increase of cytotoxicity in cocultures 
exposed to increasing concentrations of Mg extract. Additionally opposite actions 
on osteoblasts and osteoclast maturation process were observed. Higher 
magnesium concentrations (more than 6mM) enhanced osteoblast differentiation 
measured by increased ALP activity and increased mineralization. Reversely, 
increasing levels of Mg2+ in extracts favored osteoclast differentiation but higher 
than 6mM concentrations disfavored it. The differences in the findings can be 
attributed to the different cell lines used. Our study was performed with primary 
cells but the coculture in the study was performed with osteoblasts and 
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osteoclasts derived from the SCP-1 and PBMC cell line respectively (Wu, 
Feyerabend, Schilling, Willumeit-Römer, & Luthringer, 2015).  
Leidi et al.(Leidi et al., 2011) tested 0.1mM, 1.0mM and 5.0mM Mg2+ 
concentrations on SaOS-2 cells, and showed that 5.0mM Mg2+ inhibited 
mineralization activity of SaOS-2. The same study also revealed that 5.0mM Mg2+ 
concentration blocked differentiation by down regulating alkaline phosphatase 
activity on normal human osteoblast grown in osteogenic media for 19 days.  
Zhang et al.(L. Zhang et al., 2014) tested the effect of extracellular Mg2+ on 
the deposition of calcium phosphate matrix and Ca2+ signaling on human bone 
marrow-derived mesenchymal stem cells.  The magnesium range tested in this 
study was between 0.8mM and 3.8mM. The study showed that Mg2+ 
concentration over 1.3mM suppressed mineralization of mesenchymal stem cells, 
which is in agreement with studies shown that in the human body the 
concentration of freely available Mg2+ is around 0.5mM to 1.2mM. However, a 
previous study from the same group did not find a suppression effect of high Mg2+ 
osteogenic differentiation similar to other groups mentioned before as well, which 
is intriguing (C. Yang et al., 2010).  
Our study was designed to test the most complete range of supplemented 
Mg2+ concentrations (0.5mM to 16mM) on genuinely normal human osteoblasts. 
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Although Zhang et al. did not find any increase in osteocalcin levels, our study 
revealed that supplemented Mg2+ dosage does up-regulate the cells osteocalsin 
expression, but at the same time there is a limitation in the amounts of 
extracellular magnesium that is beneficial in the normal human osteoblasts. A too 
high concentration of Mg2+ does not lead to increase in proliferation or 
differentiation and in some cases would lead to cell toxicity (de Baaij, Hoenderop, 
& Bindels, 2015). 
The attachment efficiency assay results are important because the 
development of biomaterial surfaces that optimally promote osteogenic cell 
attachment and survival is a crucial factor in successful therapeutic strategies for 
bone regeneration. Zreiqat in 1999 started testing how surface modifications of 
bioceramics influence cellular behavior of human bone-derived cells in a time 
frame of two weeks. Comparing expression levels of proteins involved in 
osteogenic differentiation he discovered that cells grown on Mg-Alumina surfaces 
show an increased expression prolife of osteogenic proteins even after 5 days 
when compared to the expression prolife of cells grown only on alumina. The 
difference in expression prolife was more prominent after 14 days, clearly 
indicating that substrate chemistry affects cellular differentiation (Zreiqat, Evans, 
& Howlett, 1999).  
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Being intrigued by those results, Zreiqat in 2001 performed a second study, 
checking this time cellular adhesion of the same cell type to the same biomaterial 
surfaces. He assumed that cellular adhesion acts not only as anchorage for cells 
but also tranduces signals to the cell, which could modify cellular functions. Is has 
been known that bivalent cations like Magnesium could modify intergrin function. 
Therefore he checked this time adhesion, integrin expression and activation of 
intracellular signaling pathways. He then confirmed that cellular adhesion to the 
magnesium containing biomaterials was increased and has shown that 
alpha5beta1 and beta1 integrins were involved in this adhesion process. 
Furthermore, he has shown that tyrosine phosphorylation and expression of 
intracellular integrin dependent signaling proteins was increased on cells grown 
on alumina containing magnesium. Additionally expression of the extracellular 
matrix protein collagen 1 was increased as well (Zreiqat et al., 2002) 
Knowing the effect of the bivalent cationic magnesium on cellular adhesion, 
we were surprised to notice that our attachment efficiency results do not confirm 
Zreiqat’s findings. However, the way Mg2+ was introduced to the cells in our study 
is different. In the present study, Mg2+ was added in the media but in Zreiqat’s 
study, it was a solid coat on an Alumina plate, which could be one of the factors 
influencing the attachment of the cells. 
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Paul (Paul & Sharma, 2006) also studied cell adhesion and spreading of 
cells onto matrices containing magnesium and calcium for 24 hours and 5 days in 
vitro. They observed that on calcium phosphate matrix containing a combination 
of zinc and magnesium, the osteoblast adhesion and spreading was significant on 
5th day and comparable to hydroxyapatite. However, the cells they used to 
perform this study are again MG-63 osteosarcoma cells. In 2008 though, Vohra 
compared the adhesion of two osteosarcoma cell lines, MG-63 and Saos-2, with 
that of mesenchymal stem cells. He has shown that the immortalized 
osteosarcoma cell lines clearly prefer fibronectin as extracellular matrix to bind too, 
in distinction to bone marrow derived mesenchymal stem cells which prefer rather 
collagen for adhesion. They also revealed that binding of osteosarcomas to 
fibrinectin is mediated by integrin heterodimers, however those heterodimers are 
very different to the ones attributing to collagen binding. This finding clearly 
indicates that the adhesion mechanism of osteosarcomas is different to the 
adhesion mechanism of bone marrow derived mesenchymal stem cells, revealing 
once more that osteosarcoma cell lines are not a suitable cell system to study cell 
biomaterial interactions (Vohra, Hennessy, Sawyer, Zhuo, & Bellis, 2008). 
In the proliferation study, up-regulation could be noticed in this study during 
the entire experiment when the supplemented Mg2+ values ranged from 0.5mM to 
4mM, whereas values ≥ 8mM down-regulated proliferation compared to the 
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control group. This would possibly imply that higher concentrations of 
supplemented Mg2+ might have cytotoxicity or inhibition of growth on normal 
human osteoblasts. 
In the ALP activity and osteocalcin expression assay, the 2mM 
supplements group maintained a consistent up-regulatory effect. As in the 
proliferation study, higher concentrations (8mM and 16mM) showed significant 
down regulation on normal human osteoblast differentiation when compared to 
the control (p<0.05), but the group with 4mM supplemented Mg2+ was not 
upregulate anymore, although it was not significant down regulate the ALP activity, 
but from the result we can appreciate the decreasing trend of the effect. 
It is intriguing that the mineralization study at day 7 showed a reversed 
curve pattern compared to the above results. The higher the supplemented Mg2+ 
concentration, the lower the degree of mineralization. But the patterns after 10 
days become similar to the ones recorded from the ALP activity and osteocalcin 
expression. The inverted effect is possibly caused by delayed mineralization, 
which could be explained by the prolonged proliferation and delayed 
differentiation (Lian & Stein, 1992; Montazerolghaem, Engqvist, & Karlsson Ott, 
2013) . 
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Apparently optimal additional Mg2+ has an up-regulated proliferative and 
osteogenic effect on normal human osteoblasts, but higher supplemented Mg2+ 
concentrations would lead to less proliferative activities and less differentiate 
bone-forming cells, even to cell death. Physiologic circulating Mg2+ levels are 
approximately 1.0mM, 2mM Mg is a concentration that falls within the 
physiological/pathophysiological range, whereas 5mM is considered a very high 
concentration, which has been previously utilized in in vitro studies (Banai, 
Haggroth, Epstein, & Casscells, 1990; Maier, Bernardini, Rayssiguier, & Mazur, 
2004).  
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8. CONCLUSION 
It was concluded that 2mM Mg2+ supplemented concentration would 
significantly up-regulate proliferation, differentiation and mineralization of normal 
human osteoblast culture. This is the first report to demonstrate the optimal Mg2+ 
concentration inducing human osteogenesis, which might lead to potential 
development of clinical applications in biomaterials.  
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9. FUTURE STUDIES 
This in vitro study showed that 2mM supplemented magnesium would 
up-regulate proliferation, differentiation and mineralization of normal human 
osteoblast cells.  
 Further studies are required to determine the degradation rate of magnesium 
containing biomaterials to achieve the optimal in vivo concentrations of released 
magnesium for such magnesium-induced osteogenesis.   
    The animal studies will also be required to obtain necessary data leading to 
future clinical applications of novel magnesium containing osteogenic materials.    
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